These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31752382)

  • 1. Effectiveness of Efflux Pump Inhibitors as Biofilm Disruptors and Resistance Breakers in Gram-Negative (ESKAPEE) Bacteria.
    Reza A; Sutton JM; Rahman KM
    Antibiotics (Basel); 2019 Nov; 8(4):. PubMed ID: 31752382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?
    Yu Z; Tang J; Khare T; Kumar V
    Fitoterapia; 2020 Jan; 140():104433. PubMed ID: 31760066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps.
    Mahmood HY; Jamshidi S; Sutton JM; Rahman KM
    Curr Med Chem; 2016; 23(10):1062-81. PubMed ID: 26947776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial effluxome as a barrier against antimicrobial agents: structural biology aspects and drug targeting.
    Brindangnanam P; Sawant AR; Prashanth K; Coumar MS
    Tissue Barriers; 2022 Oct; 10(4):2013695. PubMed ID: 34957912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pangenome Analytics Reveal Two-Component Systems as Conserved Targets in ESKAPEE Pathogens.
    Rajput A; Seif Y; Choudhary KS; Dalldorf C; Poudel S; Monk JM; Palsson BO
    mSystems; 2021 Jan; 6(1):. PubMed ID: 33500331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bacterial efflux pumps in biofilm formation.
    Alav I; Sutton JM; Rahman KM
    J Antimicrob Chemother; 2018 Aug; 73(8):2003-2020. PubMed ID: 29506149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in
    Braun HG; Perera SR; Tremblay YDN; Thomassin JL
    Can J Microbiol; 2024 Dec; 70(12):507-528. PubMed ID: 39213659
    [No Abstract]   [Full Text] [Related]  

  • 8. Tripartite efflux pumps of the RND superfamily: what did we learn from computational studies?
    Athar M; Gervasoni S; Catte A; Basciu A; Malloci G; Ruggerone P; Vargiu AV
    Microbiology (Reading); 2023 Mar; 169(3):. PubMed ID: 36972322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
    Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
    mSystems; 2018; 3(3):. PubMed ID: 29719870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and Resistance of
    Ciofu O; Tolker-Nielsen T
    Front Microbiol; 2019; 10():913. PubMed ID: 31130925
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to
    Zack KM; Sorenson T; Joshi SG
    Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
    Vila J; Martínez JL
    Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances toward a molecular mechanism of efflux pump inhibition.
    Opperman TJ; Nguyen ST
    Front Microbiol; 2015; 6():421. PubMed ID: 25999939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria.
    Yang X; Goswami S; Gorityala BK; Domalaon R; Lyu Y; Kumar A; Zhanel GG; Schweizer F
    J Med Chem; 2017 May; 60(9):3913-3932. PubMed ID: 28399372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proanthocyanidin Interferes with Intrinsic Antibiotic Resistance Mechanisms of Gram-Negative Bacteria.
    Maisuria VB; Okshevsky M; Déziel E; Tufenkji N
    Adv Sci (Weinh); 2019 Aug; 6(15):1802333. PubMed ID: 31406662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
    Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
    J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal temperature measurement can determine humane endpoints in BALB/c mouse models of ESKAPEE infection.
    Dudis RS; Wong TY; Escatte MG; Alamneh YA; Abu-Taleb R; Su W; Czintos C; Fitzgerald TA; Le Breton Y; Zurawski DV
    Virulence; 2023 Dec; 14(1):2186331. PubMed ID: 36976806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Biofilm Inhibitor Carolacton Enters Gram-Negative Cells: Studies Using a TolC-Deficient Strain of
    Donner J; Reck M; Bunk B; Jarek M; App CB; Meier-Kolthoff JP; Overmann J; Müller R; Kirschning A; Wagner-Döbler I
    mSphere; 2017; 2(5):. PubMed ID: 28959742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.